https://www.businesswire.com/news/home/20260531020433/en/Faraday-Future-Founder-and-Global-CEO-YT-Jia-Shares-Weekly-Investor-Update-Total-Sales-and-Shipments-of-EAI-Robots-Reached-69-Units-in-May-a-New-Record-Exceeding-the-Combined-Total-for-the-Months-of-March-and-April 2026-05-31T23:30:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260528004124/it 2026-05-31T22:02:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260528867319/zh-HK 2026-05-31T21:56:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260528407787/pl 2026-05-31T21:49:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260528727742/hu 2026-05-31T21:44:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260531620998/en/VRRM-Investors-Have-Opportunity-to-Join-Verra-Mobility-Corporation-Fraud-Investigation-with-the-Schall-Law-Firm 2026-05-31T21:34:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260531121860/en/PLAB-Investors-Have-Opportunity-to-Join-Photronics-Inc.-Fraud-Investigation-with-the-Schall-Law-Firm 2026-05-31T21:27:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260529578327/es 2026-05-31T21:14:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260529506966/zh-HK 2026-05-31T21:14:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260529247109/ja 2026-05-31T21:14:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260529769533/de 2026-05-31T21:14:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260531595161/en/CZR-Investors-Have-the-Opportunity-to-Join-Investigation-of-Caesars-Entertainment-Inc.-with-the-Schall-Law-Firm 2026-05-31T21:05:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260531630893/en/Berkshire-Hathaway-to-Acquire-Taylor-Morrison-Home-Corporation-for-%248.5-Billion 2026-05-31T20:30:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260531916899/en/GAP-Investors-Have-Opportunity-to-Join-The-Gap-Inc.-Fraud-Investigation-with-the-Schall-Law-Firm 2026-05-31T20:29:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260531161413/en/Ivonescimab-with-Chemotherapy-Demonstrated-a-Statistically-Significant-Overall-Survival-Benefit-Compared-to-Tislelizumab-Plus-Chemotherapy-in-1L-Treatment-of-Patients-with-Squamous-NSCLC-in-the-HARMONi-6-Study-Conducted-by-Akeso-in-China 2026-05-31T13:06:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260531652876/en/Tempus-Unveils-the-Next-Generation-of-Lens-Expanding-its-Agentic-AI-Platform-for-Oncology-Drug-Development 2026-05-31T12:30:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260531990280/en/Pfizers-BRAFTOVI-Regimen-Nearly-Doubles-Median-Progression-Free-Survival-in-Metastatic-Colorectal-Cancer 2026-05-31T12:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260531412768/en/Kelonia-Therapeutics-Presents-Updated-First-in-Human-Data-from-Phase-1-inMMyCAR-Study-of-KLN-1010-in-vivo-BCMA-CAR-T-Therapy-at-the-2026-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting 2026-05-31T12:00:00.000Z weekly 0.5